These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17710352)

  • 1. Characteristics of patients initiating teriparatide for the treatment of osteoporosis.
    Foster SA; Foley KA; Meadows ES; Johnston JA; Wang S; Pohl GM; Long SR
    Osteoporos Int; 2008 Mar; 19(3):373-7. PubMed ID: 17710352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.
    Foster SA; Foley KA; Meadows ES; Johnston JA; Wang S; Pohl GM; Long SR
    BMC Womens Health; 2008 Dec; 8():24. PubMed ID: 19105828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance.
    Foster SA; Foley KA; Meadows ES; Johnston JA; Wang SS; Pohl GM; Long SR
    Osteoporos Int; 2011 Feb; 22(2):551-7. PubMed ID: 20798929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
    Hazel-Fernandez L; Louder AM; Foster SA; Uribe CL; Burge RT
    BMC Musculoskelet Disord; 2013 Jan; 14():4. PubMed ID: 23281846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
    Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
    Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status quo of osteoporosis treatment in Japan disclosed by the National Database of Health Insurance Claims and Specific Health Checkups: too late in treatment initiation and too few in treated patients?
    Kamata Y; Minota S
    Arch Osteoporos; 2019 Jul; 14(1):84. PubMed ID: 31367957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
    Imel EA; Starzyk K; Gliklich R; Weiss RJ; Wang Y; Williams SA
    Osteoporos Int; 2020 Dec; 31(12):2413-2424. PubMed ID: 32696118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis.
    Hernandez I; Zhang Y
    J Eval Clin Pract; 2015 Oct; 21(5):840-7. PubMed ID: 26059485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
    Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
    J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
    Jakob F; Oertel H; Langdahl B; Ljunggren O; Barrett A; Karras D; Walsh JB; Fahrleitner-Pammer A; Rajzbaum G; Barker C; Lems WF; Marin F
    Eur J Endocrinol; 2012 Jan; 166(1):87-97. PubMed ID: 22048967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis.
    Seki S; Hirano N; Kawaguchi Y; Nakano M; Yasuda T; Suzuki K; Watanabe K; Makino H; Kanamori M; Kimura T
    Eur Spine J; 2017 Aug; 26(8):2121-2127. PubMed ID: 28116510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of teriparatide in the clinical practice--attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment.
    Koski AM; Löyttyniemi E; Väänänen H; Laine H; Niskanen L; Nevalainen PI; Korpi-Hyövälti E; Välimäki MJ
    Ann Med; 2013 May; 45(3):230-5. PubMed ID: 23330730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months.
    Jobke B; Muche B; Burghardt AJ; Semler J; Link TM; Majumdar S
    Calcif Tissue Int; 2011 Aug; 89(2):130-9. PubMed ID: 21626160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of and switches from teriparatide treatment among women and men with osteoporosis in the real world: a claims database analysis.
    Usui T; Funagoshi M; Seto K; Ide K; Tanaka S; Kawakami K
    Arch Osteoporos; 2018 May; 13(1):54. PubMed ID: 29725863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF; Hamdy NA; Netelenbos JC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):132-7. PubMed ID: 16463613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of daily teriparatide treatment for osteoporosis in men.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2015 Apr; 26(4):1303-9. PubMed ID: 25567777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study.
    Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T
    Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.